Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments

We assessed 17 women who had undergone autologous bone marrow transplants (BMT) for their breast cancer and 20 other women who had been treated for breast cancer (but not with BMT) by structured clinical interviews examining each stage of the breast cancer experience (e.g. initial diagnosis, initial...

Full description

Saved in:
Bibliographic Details
Published in:Behaviour research and therapy Vol. 38; no. 10; pp. 1015 - 1027
Main Authors: Mundy, Elizabeth A., Blanchard, Edward B., Cirenza, Emanuel, Gargiulo, Janet, Maloy, Barbara, Blanchard, Christina G.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-10-2000
Elsevier Science
Elsevier Science Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We assessed 17 women who had undergone autologous bone marrow transplants (BMT) for their breast cancer and 20 other women who had been treated for breast cancer (but not with BMT) by structured clinical interviews examining each stage of the breast cancer experience (e.g. initial diagnosis, initial treatment, recurrence of cancer (if applicable) and BMT (if applicable)) and at follow-up points; 3, 6 and 12 months (if applicable) posttreatment. The two groups did not differ on incidence of posttraumatic stress disorder (PTSD), major depressive disorder (MDD) or generalized anxiety disorder at any stage. We found a high rate of PTSD over the cancer experience, 35% for the combined sample, with cancer diagnosis being the most likely point for developing PTSD, 27% for the combined sample. None of the 17 women who had undergone BMT developed PTSD as a result of the treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0005-7967
1873-622X
DOI:10.1016/S0005-7967(99)00144-8